AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Shuttle Pharmaceuticals Holdings, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG017Z2NGC6
4.86▲ 0.25 (5.42%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
4.61
Day's Range
3.30 – 5.18
52-Week Range
0.38 – 6.15
Volume
188.0K
Avg Volume
40.6K
Share Statistics
Shares Outstanding
Employees
2
Exchange
XNAS
Listed
2022-08-31
Share count as of September 21, 2026

Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH)
What is Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Market Cap?
Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Market Cap is $23.2M, based on as-reported figures from SEC (XBRL) filings.
What is Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Revenue (TTM)?
Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Net Income (TTM)?
Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Net Income (TTM) is -$10.3M, based on as-reported figures from SEC (XBRL) filings.
What is Shuttle Pharmaceuticals Holdings, Inc. Common Stock's EBITDA?
Shuttle Pharmaceuticals Holdings, Inc. Common Stock's EBITDA is -$9.7M, based on as-reported figures from SEC (XBRL) filings.
What is Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Diluted EPS (TTM)?
Shuttle Pharmaceuticals Holdings, Inc. Common Stock's Diluted EPS (TTM) is -2.15, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · SHPHAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses
Research and Development Expense
Selling, General and Administrative Expense
Non-Operating Income (Expense)
Total operating expenses
Net loss from operations
Net loss
Earnings Per Share (Basic)
Earnings Per Share (Diluted)